HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jing Qin Selected Research

Ovarian Neoplasms (Ovarian Cancer)

2/2021Short-Form Thymic Stromal Lymphopoietin (sfTSLP) Is the Predominant Isoform Expressed by Gynaecologic Cancers and Promotes Tumour Growth.
1/2015Maintenance Therapy in Ovarian Cancer with Targeted Agents Improves PFS and OS: A Systematic Review and Meta-Analysis.
5/2007The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jing Qin Research Topics

Disease

81Neoplasms (Cancer)
07/2022 - 05/2002
29Stomach Neoplasms (Stomach Cancer)
07/2022 - 05/2010
18Neoplasm Metastasis (Metastasis)
04/2022 - 09/2003
11Inflammation (Inflammations)
07/2021 - 04/2007
10Adenocarcinoma
07/2022 - 07/2002
10Infections
04/2022 - 08/2007
9Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2021 - 11/2008
8Breast Neoplasms (Breast Cancer)
07/2022 - 12/2007
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2020 - 03/2014
7Lung Neoplasms (Lung Cancer)
01/2020 - 04/2013
6Carcinogenesis
01/2021 - 01/2017
6Disease Progression
01/2021 - 09/2003
6Glioma (Gliomas)
07/2019 - 03/2007
6Colorectal Neoplasms (Colorectal Cancer)
10/2017 - 06/2003
5Autoimmune Diseases (Autoimmune Disease)
01/2022 - 11/2017
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 04/2013
5Carcinoma (Carcinomatosis)
01/2021 - 07/2002
5Lymphoma (Lymphomas)
04/2012 - 09/2002
5Spinal Cord Injuries (Spinal Cord Injury)
09/2008 - 02/2008
5Osteosarcoma (Osteogenic Sarcoma)
09/2008 - 06/2003
4Myocardial Infarction
05/2022 - 04/2012
4Fibrosis (Cirrhosis)
11/2020 - 02/2004
4Thyroiditis
01/2020 - 11/2017
4Crush Injuries
01/2018 - 01/2016
4Brain Neoplasms (Brain Tumor)
07/2017 - 07/2002
4Cardiovascular Diseases (Cardiovascular Disease)
07/2015 - 06/2012
4Hepatocellular Carcinoma (Hepatoma)
05/2014 - 04/2008
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2004 - 03/2003
3Adenocarcinoma of Lung
04/2022 - 10/2017
3Fever (Fevers)
04/2022 - 02/2016
3HIV Infections (HIV Infection)
01/2022 - 03/2011
3Hypoxia (Hypoxemia)
05/2021 - 06/2014
3Ovarian Neoplasms (Ovarian Cancer)
02/2021 - 05/2007
3Hypertension (High Blood Pressure)
11/2020 - 04/2015
3Peripheral Nerve Injuries
10/2020 - 07/2016
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 10/2009
3Brain Ischemia (Cerebral Ischemia)
03/2019 - 01/2017
3Thrombosis (Thrombus)
04/2015 - 04/2012
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2022 - 09/2003
2Stroke (Strokes)
05/2022 - 01/2019
2Type 2 Diabetes Mellitus (MODY)
05/2022 - 04/2014
2Chronic Granulomatous Disease
04/2022 - 08/2017
2Bacterial Infections (Bacterial Infection)
04/2022 - 05/2020
2Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2020
2Sepsis (Septicemia)
02/2021 - 03/2004
2Virus Diseases (Viral Diseases)
01/2021 - 01/2013
2Esophageal Squamous Cell Carcinoma
01/2021 - 01/2018
2COVID-19
11/2020 - 11/2020

Drug/Important Bio-Agent (IBA)

21Pharmaceutical PreparationsIBA
01/2022 - 10/2005
18Proteins (Proteins, Gene)FDA Link
07/2022 - 07/2002
13Biological ProductsIBA
01/2022 - 08/2003
11CytokinesIBA
01/2022 - 03/2007
9Biomarkers (Surrogate Marker)IBA
01/2021 - 05/2002
8Messenger RNA (mRNA)IBA
07/2021 - 06/2003
6Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 09/2006
5EnzymesIBA
07/2022 - 11/2008
5RNA (Ribonucleic Acid)IBA
01/2022 - 01/2008
5Therapeutic UsesIBA
01/2020 - 11/2013
5MicroRNAs (MicroRNA)IBA
01/2020 - 09/2015
5Liposomes (Liposome)IBA
06/2019 - 08/2007
5Imatinib Mesylate (Gleevec)FDA Link
03/2016 - 08/2009
4Anti-Bacterial Agents (Antibiotics)IBA
04/2022 - 01/2020
4Phosphotransferases (Kinase)IBA
02/2021 - 03/2007
4ChemokinesIBA
01/2021 - 06/2016
4SolutionsIBA
01/2021 - 08/2007
4Indicators and Reagents (Reagents)IBA
01/2021 - 09/2016
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2020 - 03/2007
4ErbB Receptors (EGF Receptor)IBA
04/2018 - 10/2005
4AntibodiesIBA
01/2018 - 04/2006
4VaccinesIBA
06/2014 - 04/2010
4MucinsIBA
10/2008 - 03/2003
4Methotrexate (Mexate)FDA LinkGeneric
09/2008 - 06/2003
3Estrogen ReceptorsIBA
09/2021 - 12/2007
3ParaffinIBA
11/2020 - 06/2015
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2019 - 11/2008
3Interleukin-8 (Interleukin 8)IBA
02/2018 - 09/2015
3Doxorubicin (Adriamycin)FDA LinkGeneric
06/2016 - 09/2003
2human ERBB2 proteinIBA
07/2022 - 10/2015
2SurvivinIBA
07/2022 - 05/2014
2CollagenIBA
07/2022 - 01/2020
2Alemtuzumab (Campath)FDA Link
04/2022 - 08/2017
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2019
2Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 11/2017
2DNA (Deoxyribonucleic Acid)IBA
09/2021 - 11/2003
2Docetaxel (Taxotere)FDA Link
05/2021 - 04/2013
2MicellesIBA
05/2021 - 05/2020
2Protein Isoforms (Isoforms)IBA
02/2021 - 06/2008
2KetamineFDA LinkGeneric
01/2021 - 01/2018
2AlbuminsIBA
01/2021 - 09/2018
2Contrast MediaIBA
01/2021 - 03/2020
2Formaldehyde (Formol)FDA Link
11/2020 - 01/2020
2CreatinineIBA
11/2020 - 01/2016

Therapy/Procedure

47Therapeutics
07/2022 - 07/2002
21Drug Therapy (Chemotherapy)
12/2022 - 07/2002
9Gastrectomy
11/2017 - 05/2010
6Immunotherapy
01/2021 - 10/2010
6Radiotherapy
07/2017 - 07/2002
5Adjuvant Chemotherapy
01/2022 - 01/2018
4Stem Cell Transplantation
05/2004 - 09/2002
3Lymph Node Excision (Lymph Node Dissection)
02/2021 - 05/2010